IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
about
Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-AnalysisAssociation with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from MexicoIs the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus RibavirinGenetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.
P2860
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
IFNL4 ss469415590 Variant Is A ...... d with IFN-Including Regimens.
@en
type
label
IFNL4 ss469415590 Variant Is A ...... d with IFN-Including Regimens.
@en
prefLabel
IFNL4 ss469415590 Variant Is A ...... d with IFN-Including Regimens.
@en
P2093
P2860
P356
P1476
IFNL4 ss469415590 Variant Is A ...... ed with IFN-Including Regimens
@en
P2093
Fumio Imazeki
Makoto Arai
Masato Nakamura
Osamu Yokosuka
Reina Sasaki
Shigeru Mikami
Shin Yasui
Shingo Nakamoto
Tatsuo Kanda
P2860
P304
P356
10.1155/2014/723868
P577
2014-12-08T00:00:00Z